The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Content analysis of pancreatic cancer conversations on Twitter: What matters most to users?
 
Udhayvir Singh Grewal
No Relationships to Disclose
 
Jamie Doggett
No Relationships to Disclose
 
Emil Lou
Honoraria - Boston Scientific; GlaxoSmithKline; Novocure
Consulting or Advisory Role - Boston Scientific; Minnetronix Medical; NomoCan; Novocure; Novocure; Novocure; Novocure
Research Funding - Novocure
Travel, Accommodations, Expenses - GlaxoSmithKline
 
Allyson J. Ocean
Consulting or Advisory Role - Celgene; Tyme
Speakers' Bureau - Daiichi Sankyo
Travel, Accommodations, Expenses - Daiichi Sankyo
 
Niraj Jaysukh Gusani
No Relationships to Disclose
 
Arjun Gupta
No Relationships to Disclose
 
Anirban Maitra
Honoraria - Celgene
Patents, Royalties, Other Intellectual Property - Johns Hopkins University has licensed a patent related to pancreatic cancer to Thrive Earlier Detection. I have 1.8% contribution on that patent. No royalties have been received by me.; Royalties from Hangzhou Guangkeande (Cosmos) Biotechnology Company LTD for blood based biomarkers of early pancreatic cancer. I do not own stocks in the company nor do I have any research or grant funding from them.
 
Muhammad Shaalan Beg
Consulting or Advisory Role - Array BioPharma; Boston Biomedical; Ipsen
Speakers' Bureau - Bristol-Myers Squibb; Ipsen
Research Funding - Agios (Inst); ArQule (Inst); AstraZeneca/MedImmune (Inst); Bristol-Myers Squibb (Inst); CASI Pharmaceuticals (Inst); Celgene (Inst); Five Prime Therapeutics (Inst); Genentech (Inst); ImmuneSensor Therapeutics (Inst); MedImmune (Inst); Merck Serono (Inst); Sillajen (Inst); Tolero Pharmaceuticals (Inst)